These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
3080 related items for PubMed ID: 16950949
1. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
3. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382 [Abstract] [Full Text] [Related]
4. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ, Walter Reed Health Care System Influenza Vaccine Consortium. Arch Intern Med; 2008 Dec 08; 168(22):2405-14. PubMed ID: 19064822 [Abstract] [Full Text] [Related]
7. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD, GRC27 Study Team. Pediatr Infect Dis J; 2009 Dec 08; 28(12):1099-104. PubMed ID: 19935270 [Abstract] [Full Text] [Related]
8. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination. Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y. Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353 [Abstract] [Full Text] [Related]
10. Immune response after influenza vaccination in children with cancer. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Pediatr Blood Cancer; 2005 Nov 23; 45(6):831-7. PubMed ID: 16007602 [Abstract] [Full Text] [Related]
12. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children. Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S. Medicina (B Aires); 2007 Nov 23; 67(4):351-9. PubMed ID: 17891930 [Abstract] [Full Text] [Related]
16. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ. J Infect Dis; 2008 Sep 01; 198(5):635-41. PubMed ID: 18694338 [Abstract] [Full Text] [Related]
17. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951 [Abstract] [Full Text] [Related]
18. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL, American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol; 2004 Apr 27; 113(4):717-24. PubMed ID: 15100679 [Abstract] [Full Text] [Related]